FitLife Brands (FTLF) Competitors $18.62 +0.06 (+0.32%) Closing price 04:00 PM EasternExtended Trading$18.64 +0.02 (+0.13%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. KALV, TBPH, VIR, GHRS, TERN, RZLT, TYRA, SEPN, NRIX, and SNDLShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include KalVista Pharmaceuticals (KALV), Theravance Biopharma (TBPH), Vir Biotechnology (VIR), GH Research (GHRS), Terns Pharmaceuticals (TERN), Rezolute (RZLT), Tyra Biosciences (TYRA), Septerna (SEPN), Nurix Therapeutics (NRIX), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Its Competitors KalVista Pharmaceuticals Theravance Biopharma Vir Biotechnology GH Research Terns Pharmaceuticals Rezolute Tyra Biosciences Septerna Nurix Therapeutics SNDL KalVista Pharmaceuticals (NASDAQ:KALV) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has higher earnings and valuation, KALV or FTLF? FitLife Brands has higher revenue and earnings than KalVista Pharmaceuticals. KalVista Pharmaceuticals is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKalVista PharmaceuticalsN/AN/A-$183.44M-$3.94-3.40FitLife Brands$64.47M2.71$8.98M$0.8422.17 Which has more risk & volatility, KALV or FTLF? KalVista Pharmaceuticals has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Is KALV or FTLF more profitable? FitLife Brands has a net margin of 12.63% compared to KalVista Pharmaceuticals' net margin of 0.00%. FitLife Brands' return on equity of 21.70% beat KalVista Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets KalVista PharmaceuticalsN/A -195.62% -89.96% FitLife Brands 12.63%21.70%13.45% Do analysts rate KALV or FTLF? KalVista Pharmaceuticals presently has a consensus target price of $26.43, indicating a potential upside of 97.52%. FitLife Brands has a consensus target price of $23.00, indicating a potential upside of 23.52%. Given KalVista Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe KalVista Pharmaceuticals is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KalVista Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11FitLife Brands 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer KALV or FTLF? In the previous week, KalVista Pharmaceuticals had 21 more articles in the media than FitLife Brands. MarketBeat recorded 22 mentions for KalVista Pharmaceuticals and 1 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.95 beat KalVista Pharmaceuticals' score of 0.47 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KalVista Pharmaceuticals 7 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of KALV or FTLF? 2.3% of FitLife Brands shares are held by institutional investors. 4.3% of KalVista Pharmaceuticals shares are held by company insiders. Comparatively, 61.4% of FitLife Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryFitLife Brands beats KalVista Pharmaceuticals on 11 of the 16 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$174.84M$10.52B$5.73B$10.28BDividend YieldN/A1.89%5.88%4.63%P/E Ratio22.1721.6476.7426.53Price / Sales2.7130.73526.07121.12Price / Cash17.9724.4737.2060.52Price / Book4.743.4113.946.31Net Income$8.98M$210.63M$3.29B$271.37M7 Day Performance-0.11%-0.20%0.63%2.11%1 Month Performance12.10%1.72%4.32%6.67%1 Year Performance11.90%-11.40%84.13%27.84% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.0519 of 5 stars$18.62+0.3%$23.00+23.5%+13.8%$174.84M$64.47M22.1720KALVKalVista Pharmaceuticals4.0072 of 5 stars$13.87+1.8%$26.43+90.5%+25.3%$700.71MN/A-3.52100Earnings ReportTBPHTheravance Biopharma3.3303 of 5 stars$13.90-3.5%$23.00+65.5%+70.8%$700.16M$64.38M57.93110Analyst DowngradeShort Interest ↑VIRVir Biotechnology3.5341 of 5 stars$4.89+2.0%$17.30+254.1%-38.2%$678.62M$74.21M-1.22580Analyst ForecastGHRSGH Research2.1352 of 5 stars$12.96-1.2%$32.00+147.0%+53.5%$674.05MN/A-17.5110Positive NewsTERNTerns Pharmaceuticals4.0295 of 5 stars$7.59+6.4%$15.61+105.8%-22.4%$666.83MN/A-7.3340Positive NewsAnalyst ForecastGap UpRZLTRezolute2.7298 of 5 stars$7.61+1.8%$11.67+53.4%+49.9%$662.91MN/A-6.6340News CoveragePositive NewsEarnings ReportUpcoming EarningsTYRATyra Biosciences2.3851 of 5 stars$12.39+0.6%$31.86+157.2%-38.7%$661.99MN/A-6.9820Positive NewsSEPNSepterna1.6133 of 5 stars$14.66+1.3%$26.75+82.5%N/A$653.62M$726K-1.45N/ANRIXNurix Therapeutics2.3911 of 5 stars$8.50-2.0%$29.07+242.0%-66.8%$650.96M$88.38M-3.26300News CoveragePositive NewsSNDLSNDL3.6976 of 5 stars$2.48-1.0%$4.50+81.8%+16.3%$650.37M$944.25M-9.172,516 Related Companies and Tools Related Companies KalVista Pharmaceuticals Competitors Theravance Biopharma Competitors Vir Biotechnology Competitors GH Research Competitors Terns Pharmaceuticals Competitors Rezolute Competitors Tyra Biosciences Competitors Septerna Competitors Nurix Therapeutics Competitors SNDL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTLF Stock Alerts